Strategic Investment Advisors Bio Rad Laboratories, Inc. Transaction History

Strategic Investment Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$418.69 - $503.0 $191,341 - $229,871	457 New	457 $218,000
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $30,138 - $38,815	65 Added 4.94%	1,380 $683,000
Q1 2022 Apr 28, 2022	SELL	$524.57 - $735.42 $9,442 - $13,237	-18 Reduced 1.35%	1,315 $741,000
Q4 2021 Jan 26, 2022	SELL	$708.84 - $794.68 $19,138 - $21,456	-27 Reduced 1.99%	1,333 $1.01 Million
Q3 2021 Oct 19, 2021	BUY	$657.71 - $825.77 $7,234 - $9,083	11 Added 0.82%	1,360 $1.01 Million
Q2 2021 Jul 22, 2021	BUY	$576.64 - $649.04 $53,627 - $60,360	93 Added 7.4%	1,349 $869,000
Q1 2021 Apr 14, 2021	BUY	$547.01 - $662.35 $136,752 - $165,587	250 Added 24.85%	1,256 $717,000
Q4 2020 Jan 13, 2021	BUY	$510.68 - $643.45 $513,744 - $647,310	1,006 New	1,006 $586,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.46B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.